Last reviewed · How we verify
Benzamycin (benzamycin)
Benzamycin (generic name: benzamycin) is a Macrolide drug. It is currently in unknown development for Acne vulgaris.
Benzamycin works by interacting with potassium channels to modulate their function.
Benzamycin is a small molecule modality targeting the potassium voltage-gated channel subfamily H member 2. It is used to treat acne vulgaris, but its commercial status and FDA approval status are unknown. As a small molecule, Benzamycin works by interacting with its target to modulate its function. The exact mechanism of action is not well-documented, but it is likely involved in the regulation of potassium channels. Further research is needed to fully understand its pharmacology.
At a glance
| Generic name | benzamycin |
|---|---|
| Drug class | Macrolide |
| Target | Potassium voltage-gated channel subfamily H member 2 |
| Therapeutic area | Dermatology |
| Phase | unknown |
Mechanism of action
Think of potassium channels like gates that control the flow of potassium ions in and out of cells. When these gates are open, potassium ions can flow out, and when they're closed, they can't. Benzamycin likely helps to regulate the opening and closing of these gates, which can help to reduce inflammation and other symptoms associated with acne.
Approved indications
- Acne vulgaris
Common side effects
- ocular irritations
- redness
- hypersensitivity reactions
Drug interactions
- High Risk QT Prolonging Agents
- P-glycoprotein Substrates
- disopyramide
- droperidol
- eszopiclone
- felodipine
- fentanyl
- fosamprenavir
- gatifloxacin
- gemifloxacin
- halofantrine
- indinavir
Key clinical trials
- ANTERO-4: VIPUN Gastric Monitoring System in an Erythromycin Model (NA)
- Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia (PHASE2,PHASE3)
- Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus (PHASE1)
- Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways (NA)
- Intravenous Erythromycin Before Endoscopy in Patients With Variceal Bleeding: A Randomized, Double-Blind Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benzamycin CI brief — competitive landscape report
- Benzamycin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Benzamycin
What is Benzamycin?
How does Benzamycin work?
What is Benzamycin used for?
What is the generic name of Benzamycin?
What drug class is Benzamycin in?
What development phase is Benzamycin in?
What are the side effects of Benzamycin?
What does Benzamycin target?
Related
- Drug class: All Macrolide drugs
- Target: All drugs targeting Potassium voltage-gated channel subfamily H member 2
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Acne vulgaris
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing